What is Phase Focus?
Phase Focus Limited is a specialist in advanced live cell imaging technology, renowned for its product Livecyte. This innovative solution leverages patented quantitative phase imaging techniques to automate cell tracking and analysis, supporting critical research in areas such as cell proliferation, motility, wound healing, and oncology. The company's technology is designed for researchers and institutions within the life sciences sector, offering versatile assays and dedicated support to enhance biological research outcomes. Phase Focus has garnered multiple innovation awards, validating its unique approach to characterizing live cell behavior.
How much funding has Phase Focus raised?
Phase Focus has raised a total of $6.8M across 3 funding rounds:
Unspecified
$1.2M
Unspecified
$571K
Unspecified
$5M
Unspecified (2008): $1.2M with participation from Spirit Capital Partners and Fusion IP
Unspecified (2009): $571K led by South Yorkshire Investment fund, Maven Capital Partners UK, and Yorkshire association of business angels
Unspecified (2012): $5M supported by Ombu Group
Key Investors in Phase Focus
Ombu Group
Ombu Group is an investment firm that provides substantial backing and management support to advanced environmental technology companies, focusing on building sustainable and durable businesses through deep strategic and operational guidance.
Spirit Capital Partners
Spirit Capital is an independent private equity fund manager focused on creating capital value in the UK SME segment through active asset management, seeking opportunities to invest up to £7 million in new private equity ventures.
South Yorkshire Investment fund
South Yorkshire Investment Fund provides seedcorn, loan, and equity-linked investments ranging from £15k to £2.5m to help small and medium businesses achieve growth and development, acting as a private and public sector business finance provider.
What's next for Phase Focus?
The substantial enterprise-level funding and recent strategic investment indicate Phase Focus is poised for significant scaling and further technological development. This capital infusion is likely to accelerate product innovation, expand market reach, and bolster research and development efforts. The company's focus on advanced live cell imaging positions it to capitalize on the growing demand for sophisticated biological analysis tools, suggesting a trajectory towards market leadership and potential further strategic partnerships or acquisitions.
See full Phase Focus company page
